NCT00884546 2016-09-30
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
Bristol-Myers Squibb
Phase 1 Completed
Clinical Trials
4 trialsNCT00670189 2014-08-15
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
Bristol-Myers Squibb
Phase 1 Completed
NCT00909402 2013-06-21
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Bristol-Myers Squibb
Phase 1 Completed
NCT01413906 2013-06-03
Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed